Unapproved Sildenafil Tablets Recalled by FDA for Lack of Safety Data
The FDA is recalling ZHANSHENG WEIGE CHAOYUE XILISHI tablets because they contain sildenafil, an unapproved drug for which safety and efficacy have not been established.
- Product
- ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language
- Category
- Drug
- Distribution
- 2 states